{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:12:47Z","timestamp":1779358367412,"version":"3.51.4"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NIH","award":["K23MH127465"],"award-info":[{"award-number":["K23MH127465"]}]},{"name":"NIH","award":["K24MH120568"],"award-info":[{"award-number":["K24MH120568"]}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","award":["NARSAD"],"award-info":[{"award-number":["NARSAD"]}],"id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018644","name":"Boston Nutrition Obesity Research Center, Boston University","doi-asserted-by":"publisher","award":["Pilot and Feasibility Grant"],"award-info":[{"award-number":["Pilot and Feasibility Grant"]}],"id":[{"id":"10.13039\/100018644","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016758","name":"Nutrition Obesity Research Center at Harvard","doi-asserted-by":"publisher","award":["P30DK040561"],"award-info":[{"award-number":["P30DK040561"]}],"id":[{"id":"10.13039\/100016758","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MGH","award":["Claflin Distinguished Scholar Award"],"award-info":[{"award-number":["Claflin Distinguished Scholar Award"]}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["AR220116 HT9425-23-1-0219"],"award-info":[{"award-number":["AR220116 HT9425-23-1-0219"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Templeton Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04529-9","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T08:10:24Z","timestamp":1773130224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of intranasal oxytocin plasma proteome signatures"],"prefix":"10.1007","volume":"91","author":[{"given":"Lauren","family":"Breithaupt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie G.","family":"Harshman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick M.","family":"Botros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Holman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regine","family":"Boutin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Galbiati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Aulinas","family":"Maso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Soukas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruslan I.","family":"Sadreyev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shana E.","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Lawson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"issue":"3","key":"4529_CR1","first-page":"97","volume":"39","author":"A Kiss","year":"2005","unstructured":"A. Kiss, J.D. Mikkelsen, Oxytocin-anatomy and functional assignments: a minireview. Endocr. Regul. 39(3), 97\u2013105 (2005)","journal-title":"Endocr. Regul."},{"issue":"8","key":"4529_CR2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00592-017-0994-x","volume":"54","author":"CA Roberts","year":"2017","unstructured":"C.A. Roberts, P. Christiansen, J.C.G. Halford, Tailoring pharmacotherapy to specific eating behaviours in obesity: can recommendations for personalised therapy be made from the current data? Acta Diabetol. 54(8), 715\u2013725 (2017)","journal-title":"Acta Diabetol."},{"issue":"3","key":"4529_CR3","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.biopsych.2015.08.008","volume":"79","author":"R Feldman","year":"2016","unstructured":"R. Feldman, M. Monakhov, M. Pratt, R.P. Ebstein, Oxytocin pathway genes: evolutionary ancient system impacting on human affiliation, sociality, and psychopathology. Biol. Psychiatry 79(3), 174\u2013184 (2016)","journal-title":"Biol. Psychiatry"},{"key":"4529_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.neubiorev.2017.05.007","volume":"80","author":"ER Bradley","year":"2017","unstructured":"E.R. Bradley, J.D. Woolley, Oxytocin effects in schizophrenia: reconciling mixed findings and moving forward. Neurosci. Biobehav. Rev. 80, 36\u201356 (2017)","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"Pt 11","key":"4529_CR5","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1093\/brain\/awu231","volume":"137","author":"Y Aoki","year":"2014","unstructured":"Y. Aoki, N. Yahata, T. Watanabe et al. Oxytocin improves behavioural and neural deficits in inferring others\u2019 social emotions in autism. Brain 137(Pt 11), 3073\u20133086 (2014)","journal-title":"Brain"},{"key":"4529_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.yhbeh.2015.05.015","volume":"77","author":"M Numan","year":"2016","unstructured":"M. Numan, L.J. Young, Neural mechanisms of mother-infant bonding and pair bonding: similarities, differences, and broader implications. Horm. Behav. 77, 98\u2013112 (2016)","journal-title":"Horm. Behav."},{"issue":"12","key":"4529_CR7","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nrendo.2017.115","volume":"13","author":"EA Lawson","year":"2017","unstructured":"E.A. Lawson, The effects of oxytocin on eating behaviour and metabolism in humans. Nat. Rev. Endocrinol. 13(12), 700\u2013709 (2017)","journal-title":"Nat. Rev. Endocrinol."},{"issue":"9","key":"4529_CR8","doi-asserted-by":"publisher","first-page":"e25565","DOI":"10.1371\/journal.pone.0025565","volume":"6","author":"N Deblon","year":"2011","unstructured":"N. Deblon, C. Veyrat-Durebex, L. Bourgoin et al. Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. PLoS One 6(9), e25565 (2011)","journal-title":"PLoS One"},{"issue":"3","key":"4529_CR9","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.neuron.2010.12.036","volume":"69","author":"G Zhang","year":"2011","unstructured":"G. Zhang, H. Bai, H. Zhang et al. Neuropeptide exocytosis involving synaptotagmin-4 and oxytocin in hypothalamic programming of body weight and energy balance. Neuron 69(3), 523\u2013535 (2011)","journal-title":"Neuron"},{"issue":"5","key":"4529_CR10","doi-asserted-by":"publisher","first-page":"e61477","DOI":"10.1371\/journal.pone.0061477","volume":"8","author":"H Zhang","year":"2013","unstructured":"H. Zhang, C. Wu, Q. Chen et al. Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models. PLoS One 8(5), e61477 (2013)","journal-title":"PLoS One"},{"issue":"12","key":"4529_CR11","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.18632\/aging.100408","volume":"3","author":"Y Maejima","year":"2011","unstructured":"Y. Maejima, Y. Iwasaki, Y. Yamahara, M. Kodaira, U. Sedbazar, T. Yada, Peripheral oxytocin treatment ameliorates obesity by reducing food intake and visceral fat mass. Aging 3(12), 1169\u20131177 (2011)","journal-title":"Aging"},{"issue":"11","key":"4529_CR12","doi-asserted-by":"publisher","first-page":"4189","DOI":"10.1210\/en.2014-1466","volume":"155","author":"J Altirriba","year":"2014","unstructured":"J. Altirriba, A.-L. Poher, A. Caillon et al. Divergent effects of oxytocin treatment of obese diabetic mice on adiposity and diabetes. Endocrinology 155(11), 4189\u20134201 (2014)","journal-title":"Endocrinology"},{"issue":"5","key":"4529_CR13","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1002\/oby.21069","volume":"23","author":"EA Lawson","year":"2015","unstructured":"E.A. Lawson, D.A. Marengi, R.L. DeSanti, T.M. Holmes, D.A. Schoenfeld, C.J. Tolley, Oxytocin reduces caloric intake in men. Obesity 23(5), 950\u2013956 (2015)","journal-title":"Obesity"},{"issue":"11","key":"4529_CR14","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1038\/ijo.2016.149","volume":"40","author":"M Thienel","year":"2016","unstructured":"M. Thienel, A. Fritsche, M. Heinrichs et al. Oxytocin\u2019s inhibitory effect on food intake is stronger in obese than normal-weight men. Int. J. Obes. 40(11), 1707\u20131714 (2016)","journal-title":"Int. J. Obes."},{"issue":"2","key":"4529_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1210\/endrev\/bnz012","volume":"41","author":"SE McCormack","year":"2020","unstructured":"S.E. McCormack, J.E. Blevins, E.A. Lawson, Metabolic effects of oxytocin. Endocr. Rev. 41(2), 121\u2013145 (2020)","journal-title":"Endocr. Rev."},{"key":"4529_CR16","doi-asserted-by":"crossref","unstructured":"K\u00fcbler U. Structured Clinical Interview for DSM-IV (SCID). In: Gellman M.D., Turner J.R., editors. Encyclopedia of Behavioral Medicine. New York, NY: Springer New York; 2013. pp. 1919\u20131920.","DOI":"10.1007\/978-1-4419-1005-9_66"},{"issue":"23","key":"4529_CR17","doi-asserted-by":"publisher","first-page":"7153","DOI":"10.1073\/pnas.1507719112","volume":"112","author":"Y Hathout","year":"2015","unstructured":"Y. Hathout, E. Brody, P.R. Clemens et al. Large-scale serum protein biomarker discovery in duchenne muscular dystrophy. Proc. Natl Acad. Sci. USA 112(23), 7153\u20137158 (2015)","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"49","key":"4529_CR18","doi-asserted-by":"publisher","first-page":"19971","DOI":"10.1073\/pnas.1213933109","volume":"109","author":"DR Davies","year":"2012","unstructured":"D.R. Davies, A.D. Gelinas, C. Zhang et al. Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targets. Proc. Natl Acad. Sci. USA 109(49), 19971\u201319976 (2012)","journal-title":"Proc. Natl Acad. Sci. USA"},{"issue":"2065","key":"4529_CR19","first-page":"20150202","volume":"374","author":"IT Jolliffe","year":"2016","unstructured":"I.T. Jolliffe, J. Cadima, Principal component analysis: a review and recent developments. Philos. Trans. A Math. Phys. Eng. Sci. 374(2065), 20150202 (2016)","journal-title":"Philos. Trans. A Math. Phys. Eng. Sci."},{"issue":"2","key":"4529_CR20","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1093\/beheco\/arn145","volume":"20","author":"H Schielzeth","year":"2009","unstructured":"H. Schielzeth, W. Forstmeier, Conclusions beyond support: overconfident estimates in mixed models. Behav. Ecol. 20(2), 416\u2013420 (2009)","journal-title":"Behav. Ecol."},{"key":"4529_CR21","doi-asserted-by":"crossref","unstructured":"Barr D.J., Levy R., Scheepers C., Tily H.J. Random effects structure for confirmatory hypothesis testing: keep it maximal. J Mem Lang 2013;68(3). Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3881361\/","DOI":"10.1016\/j.jml.2012.11.001"},{"issue":"1","key":"4529_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/obr.12757","volume":"20","author":"C Ding","year":"2019","unstructured":"C. Ding, M.K.-S. Leow, F. Magkos, Oxytocin in metabolic homeostasis: implications for obesity and diabetes management. Obes. Rev. 20(1), 22\u201340 (2019)","journal-title":"Obes. Rev."},{"key":"4529_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134561","volume":"714","author":"L Banki","year":"2020","unstructured":"L. Banki, A. B\u00fcki, G. Horvath et al. Distinct changes in chronic pain sensitivity and oxytocin receptor expression in a new rat model (Wisket) of schizophrenia. Neurosci. Lett. 714, 134561 (2020)","journal-title":"Neurosci. Lett."},{"issue":"9","key":"4529_CR24","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.psyneuen.2013.02.002","volume":"38","author":"M Gil","year":"2013","unstructured":"M. Gil, R. Bhatt, K.B. Picotte, E.M. Hull, Sexual experience increases oxytocin receptor gene expression and protein in the medial preoptic area of the male rat. Psychoneuroendocrinology 38(9), 1688\u20131697 (2013)","journal-title":"Psychoneuroendocrinology"},{"key":"4529_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108082","volume":"171","author":"A Romano","year":"2020","unstructured":"A. Romano, M. Friuli, C. Cifani, S. Gaetani, Oxytocin in the neural control of eating: at the crossroad between homeostatic and non-homeostatic signals. Neuropharmacology 171, 108082 (2020)","journal-title":"Neuropharmacology"},{"issue":"3","key":"4529_CR26","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1152\/physrev.00031.2017","volume":"98","author":"B Jurek","year":"2018","unstructured":"B. Jurek, I.D. Neumann, The oxytocin receptor: from intracellular signaling to behavior. Physiol. Rev. 98(3), 1805\u20131908 (2018)","journal-title":"Physiol. Rev."},{"issue":"44","key":"4529_CR27","doi-asserted-by":"publisher","first-page":"15476","DOI":"10.1523\/JNEUROSCI.2429-12.2012","volume":"32","author":"Y-T Lin","year":"2012","unstructured":"Y.-T. Lin, C.-C. Huang, K.-S. Hsu, Oxytocin promotes long-term potentiation by enhancing epidermal growth factor receptor-mediated local translation of protein kinase M\u03b6. J. Neurosci. 32(44), 15476\u201315488 (2012)","journal-title":"J. Neurosci."},{"issue":"1","key":"4529_CR28","first-page":"33","volume":"13","author":"WR Crowley","year":"1992","unstructured":"W.R. Crowley, W.E. Armstrong, Neurochemical regulation of oxytocin secretion in lactation. Endocr. Rev. 13(1), 33\u201365 (1992)","journal-title":"Endocr. Rev."},{"issue":"4","key":"4529_CR29","first-page":"219","volume":"2","author":"H Sorg","year":"2017","unstructured":"H. Sorg, E. Grambow, E. Eckl, B. Vollmar, Oxytocin effects on experimental skin wound healing. Innov. Surg. Sci. 2(4), 219\u2013232 (2017)","journal-title":"Innov. Surg. Sci."},{"key":"4529_CR30","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.neuroscience.2017.10.008","volume":"366","author":"OA Klockars","year":"2017","unstructured":"O.A. Klockars, J.R. Waas, A. Klockars, A.S. Levine, P.K. Olszewski, Neural basis of ventromedial hypothalamic oxytocin-driven decrease in appetite. Neuroscience 366, 54\u201361 (2017)","journal-title":"Neuroscience"},{"issue":"5","key":"4529_CR31","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/s41366-019-0489-7","volume":"44","author":"L Kerem","year":"2020","unstructured":"L. Kerem, N. Hadjikhani, L. Holsen, E.A. Lawson, F. Plessow, Oxytocin reduces the functional connectivity between brain regions involved in eating behavior in men with overweight and obesity. Int. J. Obes. 44(5), 980\u2013989 (2020)","journal-title":"Int. J. Obes."},{"issue":"3","key":"4529_CR32","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/npp.2017.226","volume":"43","author":"F Plessow","year":"2018","unstructured":"F. Plessow, D.A. Marengi, S.K. Perry et al. Effects of intranasal oxytocin on the blood oxygenation level-dependent signal in food motivation and cognitive control pathways in overweight and obese men. Neuropsychopharmacology 43(3), 638\u2013645 (2018)","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"4529_CR33","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.tem.2019.04.011","volume":"30","author":"N Rabbani","year":"2019","unstructured":"N. Rabbani, P.J. Thornalley, Hexokinase-2 glycolytic overload in diabetes and ischemia-reperfusion injury. Trends Endocrinol. Metab. 30(7), 419\u2013431 (2019)","journal-title":"Trends Endocrinol. Metab."},{"key":"4529_CR34","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neuint.2019.03.012","volume":"126","author":"M MacLean","year":"2019","unstructured":"M. MacLean, J. Derk, H.H. Ruiz, J.K. Juranek, R. Ramasamy, A.M. Schmidt, The receptor for advanced glycation end products (RAGE) and DIAPH1: implications for vascular and neuroinflammatory dysfunction in disorders of the central nervous system. Neurochem. Int. 126, 154\u2013164 (2019)","journal-title":"Neurochem. Int."},{"key":"4529_CR35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fendo.2013.00105","volume":"4","author":"Y Yamamoto","year":"2013","unstructured":"Y. Yamamoto, H. Yamamoto, RAGE-Mediated inflammation, Type 2 diabetes, and diabetic vascular complication. Front. Endocrinol. 4, 105 (2013)","journal-title":"Front. Endocrinol."},{"issue":"Pt 3","key":"4529_CR36","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1042\/bj20021371","volume":"370","author":"H Yonekura","year":"2003","unstructured":"H. Yonekura, Y. Yamamoto, S. Sakurai et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem. J. 370(Pt 3), 1097\u20131109 (2003)","journal-title":"Biochem. J."},{"issue":"9","key":"4529_CR37","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.2337\/db06-0221","volume":"55","author":"K-M Myint","year":"2006","unstructured":"K.-M. Myint, Y. Yamamoto, T. Doi et al. RAGE control of diabetic nephropathy in a mouse model: effects of RAGE gene disruption and administration of low-molecular weight heparin. Diabetes 55(9), 2510\u20132522 (2006)","journal-title":"Diabetes"},{"key":"4529_CR38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s42003-019-0325-6","volume":"2","author":"Y Yamamoto","year":"2019","unstructured":"Y. Yamamoto, M. Liang, S. Munesue et al. Vascular RAGE transports oxytocin into the brain to elicit its maternal bonding behaviour in mice. Commun. Biol. 2, 76 (2019)","journal-title":"Commun. Biol."},{"key":"4529_CR39","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.bbi.2020.07.032","volume":"89","author":"WH Walker 2nd","year":"2020","unstructured":"W.H. Walker 2nd, O.H. Mel\u00e9ndez-Fern\u00e1ndez, J.L. Pascoe, N. Zhang, A.C. DeVries, Social enrichment attenuates chemotherapy induced pro-inflammatory cytokine production and affective behavior via oxytocin signaling. Brain Behav. Immun. 89, 451\u2013464 (2020)","journal-title":"Brain Behav. Immun."},{"issue":"5","key":"4529_CR40","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.psyneuen.2012.08.009","volume":"38","author":"A Szeto","year":"2013","unstructured":"A. Szeto, M.A. Rossetti, A.J. Mendez et al. Oxytocin administration attenuates atherosclerosis and inflammation in watanabe heritable hyperlipidemic rabbits. Psychoneuroendocrinology 38(5), 685\u2013693 (2013)","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"4529_CR41","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1210\/en.2014-1718","volume":"156","author":"E Plante","year":"2015","unstructured":"E. Plante, A. Menaouar, B.A. Danalache et al. Oxytocin treatment prevents the cardiomyopathy observed in obese diabetic male db\/db mice. Endocrinology 156(4), 1416\u20131428 (2015)","journal-title":"Endocrinology"},{"key":"4529_CR42","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.bbi.2021.06.012","volume":"97","author":"W Qiu","year":"2021","unstructured":"W. Qiu, K.A. Go, Y. Wen, P. Duarte-Guterman, R.S. Eid, L.A.M. Galea, Maternal fluoxetine reduces hippocampal inflammation and neurogenesis in adult offspring with sex-specific effects of periadolescent oxytocin. Brain Behav. Immun. 97, 394\u2013409 (2021)","journal-title":"Brain Behav. Immun."},{"key":"4529_CR43","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.bbi.2024.03.013","volume":"118","author":"T Wakuda","year":"2024","unstructured":"T. Wakuda, S. Benner, Y. Uemura et al. Oxytocin-induced increases in cytokines and clinical effect on the core social features of autism: analyses of RCT datasets. Brain Behav. Immun. 118, 398\u2013407 (2024)","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"4529_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0541-7","volume":"13","author":"L Yuan","year":"2016","unstructured":"L. Yuan, S. Liu, X. Bai et al. Oxytocin inhibits lipopolysaccharide-induced inflammation in microglial cells and attenuates microglial activation in lipopolysaccharide-treated mice. J. Neuroinflammation 13(1), 77 (2016)","journal-title":"J. Neuroinflammation"},{"key":"4529_CR45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fncel.2017.00069","volume":"11","author":"Y Mizoguchi","year":"2017","unstructured":"Y. Mizoguchi, A. Monji, Microglial intracellular Ca2+ signaling in synaptic development and its alterations in neurodevelopmental disorders. Front. Cell Neurosci. 11, 69 (2017)","journal-title":"Front. Cell Neurosci."},{"issue":"2","key":"4529_CR46","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1152\/physrev.00011.2010","volume":"91","author":"H Kettenmann","year":"2011","unstructured":"H. Kettenmann, U.-K. Hanisch, M. Noda, A. Verkhratsky, Physiology of microglia. Physiol. Rev. 91(2), 461\u2013553 (2011)","journal-title":"Physiol. Rev."},{"key":"4529_CR47","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fphys.2019.00362","volume":"10","author":"N Kurgan","year":"2019","unstructured":"N. Kurgan et al. Changes to the human serum proteome in response to high intensity interval exercise: a sequential top-down proteomic analysis. Front. Physiol. 10, 362 (2019)","journal-title":"Front. Physiol."},{"key":"4529_CR48","doi-asserted-by":"publisher","first-page":"108953","DOI":"10.1016\/j.steroids.2021.108953","volume":"178","author":"R Roy","year":"2022","unstructured":"R. Roy et al. Acute serum protein and cytokine response of single dose of prednisone in adult volunteers. Steroids 178, 108953 (2022)","journal-title":"Steroids"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04529-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04529-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04529-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T10:04:29Z","timestamp":1779357869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04529-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4529"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04529-9","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LB is a consultant for Otsuka. SEM serves as site PI for Rhythm Pharmaceuticals clinical trials of setmelanotide. EAL receives grant support and research study drug from Tonix Pharmaceuticals and receives royalties from UpToDate. EAL and\/or immediate family member holds stock in Thermo Fisher Scientific, Zoetis, Danaher Corporation, Intuitive Surgical. EAL is an inventor on US provisional patent applications no. 63\/413,657 (Oxytocin-based therapeutics for bone health in individuals with autism) and no. 63\/467,980 (Oxytocin-based therapeutics to improve cognitive control in individuals with attention deficit hyperactivity disorder). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Research Resources, the National Center for Advancing Translational Science or the National Institutes of Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"111"}}